The US Orphan Drug Act: Rare disease research stimulator or commercial opportunity?
-
Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s0047272710001751-mainDownload
-
Wyeth denied patent for cancer drug – Courtesy ( The Financial Express)
Pharma Live, , Intellectual Property Rights, 0
Wyeth, which was acquired by US- based pharma major Pfizer Inc, has suffered a major setback in India with...
-
Judge Finds Biosimilar Patent Procedures Optional – Courtesy (Pharma Patent)
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 23 MARCH 2015POSTED IN BIOSIMILARSJudge Seeborg of the U.S. District Court for the Northern District of...
-
A cross-country index of intellectual property rights inpharmaceutical inventions
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s0048733314001164-mainDownload
-
Pfizer Trying To Overcome Patent Cliff – Courtesy (Seeking Alpha)
Pharma Live, , Intellectual Property Rights, 0
Pfizer Inc. (NYSE:PFE) is trying to overcome the patent cliff that has seen its recent quarter results suffer by...
-
Novo Nordisk rejects Baxter patent claim over Novoeight
Pharma Live, , Intellectual Property Rights, 0
COPENHAGEN, May 20 (Reuters) – Novo Nordisk said on Wednesday it rejected claims by U.S. rival Baxter International that...
-
Merck scores victory in India patent battle over top diabetes meds! – Courtesy (Fierce Pharma)
Pharma Live, , Intellectual Property Rights, 0
In a potentially promising sign for Western drugmakers, Merck ($MRK) scored a victory in its patent battle with India’s Glenmark...
-
Teva Pharmaceutical (TEVA) Sued By VIVUS, Inc. (VVUS) For Qsymia Patent Infringement – Courtesy(bidnessetc.com)
Pharma Live, , Intellectual Property Rights, 0
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has been sued in the US District Court for the District of New...
![](https://interactivepharm.com/wp-content/uploads/2022/08/Show-your.jpg)